NCT05291845View on ClinicalTrials.gov

Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts

PHASE2RecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

April 3, 2022

Primary Completion Date

October 3, 2025

Study Completion Date

December 6, 2025

Conditions
WartsHuman Papilloma Virus
Interventions
BIOLOGICAL

Candida antigen vaccine

we will study the efficacy and safety of agent in the treatment of multiple warts, we will follow up the recurrence rate of each group

BIOLOGICAL

Bivalent HPV vaccine

we will study the efficacy and safety of agent in the treatment of multiple warts, we will follow up the recurrence rate of each group

Trial Locations (1)

2543

RECRUITING

Reham Essam, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV